Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Strides Pharma Science Ltd
Press Release Oct 04 2023
Business
Oct 4 2023
3 min read

Press Release Oct 04 2023

Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 04, 2023, titled "Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets".

View Attachment